Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 24 (3), 161-167

Methylated Organic Metabolites of Arsenic and Their Cardiovascular Toxicities


Methylated Organic Metabolites of Arsenic and Their Cardiovascular Toxicities

Ok-Nam Bae et al. Toxicol Res.


Recently, arsenic-toxicity has become the major focus of strenuous assessment and dynamic research from the academy and regulatory agency. To elucidate the cause and the mechanism underlying the serious adverse health effects from chronic ingestion of arsenic-contaminated drinking water, numerous studies have been directed on the investigation of arsenic-toxicity using various in vitro as well as in vivo systems. Neverthless, some questions for arsenic effects remain unexplained, reflecting the contribution of unknown factors to the manifestation of arsenic-toxicity. Interestingly, very recent studies on arsenic metabolites have discovered that trivalent methylated arsenicals show stronger cytotoxic and genotoxic potentials than inorganic arsenic or pentavalent metabolites, arguing that these metabolites could play a key role in arsenic-associated disorders. In this review, recent progress and literatures are summarized on the metabolism of trivalent methylated metabolites and their toxicity on body systems including cardiovascular system in an effort to provide an insight into the future research on arsenic-associated disorders.

Keywords: Arsenic; DMAIII; MMAIII; Toxicity; Trivalent arsenic metabolite.

Similar articles

See all similar articles


    1. Abernathy CO, Thomas DJ, Calderon RL. Health effects and risk assessment of arsenic. J. Nutr. 2003;133:1536S–1538S. doi: 10.1093/jn/133.5.1536S. - DOI - PubMed
    1. Aposhian HV. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 1997;37:397–419. doi: 10.1146/annurev.pharmtox.37.1.397. - DOI - PubMed
    1. Aposhian HV, Gurzau ES, Le XC, Gurzau A, Healy SM, Lu X, Ma M, Yip L, Zakharyan RA, Maiorino RM, Dart RC, Tircus MG, Gonzalez-Ramirez D, Morgan DL, Avram D, Aposhian MM. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 2000;13:693–697. doi: 10.1021/tx000114o. - DOI - PubMed
    1. Aposhian HV, Zheng B, Aposhian MM, Le XC, Cebrian ME, Cullen W, Zakharyan RA, Ma M, Dart RC, Cheng Z, Andrewes P Y L, O’Malley GF, Maiorino RM, Van Voorhies W, Healy SM, Titcomb A. DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine. Toxicol. Appl. Pharmacol. 2000;165:74–83. doi: 10.1006/taap.2000.8922. - DOI - PubMed
    1. Aposhian HV, Zakharyan RA, Avram MD, Sampayo-Reyes A, Wollenberg ML. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. Toxicol. Appl. Pharmacol. 2004;198:327–335. doi: 10.1016/j.taap.2003.10.027. - DOI - PubMed